Conavi Medical Corp.
CNVI.V
TSX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -40.22% | -41.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -40.22% | -41.31% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -40.22% | -35.51% | |||
| SG&A Expenses | -10.26% | 47.74% | |||
| Depreciation & Amortization | -2.40% | -8.13% | |||
| Other Operating Expenses | -109.55% | 2,101.72% | |||
| Total Operating Expenses | -11.98% | -2.83% | |||
| Operating Income | 10.78% | 0.06% | |||
| Income Before Tax | -77.45% | 60.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -77.45% | 60.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -77.45% | 60.67% | |||
| EBIT | 10.78% | 0.06% | |||
| EBITDA | 11.00% | -0.17% | |||
| EPS Basic | -36.36% | 60.41% | |||
| Normalized Basic EPS | -43.04% | 60.40% | |||
| EPS Diluted | -36.36% | 60.41% | |||
| Normalized Diluted EPS | -43.04% | 60.40% | |||
| Average Basic Shares Outstanding | 30.15% | -0.57% | |||
| Average Diluted Shares Outstanding | 30.15% | -0.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||